Formulation Development

Formulation Development

Products
Formulation Development
Formulation Development

Information

Within early development, there are a variety of different challenges that hinder a molecule's ability to progress to the next phase such as complex formulation. The complexity of formulation development has been on the rise, which is driven by a variety of different factors including: Orphan drugs: This market is projected to grow at 13% CAGR from 2020-2024 mRNA therapeutics: Prior to the COVID-19 Pandemic, the global mRNA therapeutics market was estimated to reach ~3B by 2026 Repurposed drugs: Costs of bringing a repurposed drug to market have been estimated to be US$300 million on average, compared with an estimated ~$2-3 billion for a new chemical entity. Thermo Fisher's team of experts can help you solve the most complex formulation challenges through a variety of services including: • Pref...
Supplied From
United States
All categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Drug Formulation (general category)Formulation developmentPharmaceutical Machinery & TechnologyProductsServices
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Pharmaceutical Machinery & Technology
Thermo Fisher Scientific7B18Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing through our Patheon brand. We partner with customers in the pharmaceutical, biotech, and life science industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership - bonded by key elements such as trust, communication and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. With more than 60 locations around the world, we are committed to providing Accelerator(TM) Drug Development, 360˚ CDMO and CRO solutions, to support our customers' aspirations to get treatments to patients, faster. Our pharma services include API, biologics, cell therapy, viral vectors, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We couple our scientific and technical excellence in all areas with a strategic partnership, to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia. At Thermo Fisher Scientific, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach the market. As a global, full-service CDMO and CRO partner, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.

Join the event!